Omeprazole

Product NDC: 50268-619
11-digit product format: 502680619
Labeler code: 50268
Product ID: 50268-619_90cf2a57-479c-4250-b64b-874726a7170a
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: omeprazole
Dosage form: CAPSULE, DELAYED RELEASE
Route: ORAL
Labeler: AvPAK
Application: ANDA075410
Marketing category: ANDA
Marketing start: 2011-07-12
Marketing end: 0000-00-00
Substance: OMEPRAZOLE
Active strength: 20 mg/1
Pharmacologic classes: Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	50268-619		D	Discontinued by firm		2026-07-31
excluded package	package	50268-619	50268-619-15	D	Discontinued by firm		2026-07-31

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A075410-001	OMEPRAZOLE	OMEPRAZOLE	10MG	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2002-11-01
A075410-002	OMEPRAZOLE	OMEPRAZOLE	20MG	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2002-11-01
A075410-003	OMEPRAZOLE	OMEPRAZOLE	40MG	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2009-01-23

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A075410-001	AB
A075410-002	AB
A075410-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-01 22:54:32	2026-06	A075410-001	OMEPRAZOLE	10MG	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2002-11-01	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A075410-002	OMEPRAZOLE	20MG	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2002-11-01	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A075410-003	OMEPRAZOLE	40MG	CAPSULE, DELAYED REL PELLETS / ORAL	AB	2009-01-23	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-01 22:54:32	2026-06	A075410-001	AB	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A075410-002	AB	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A075410-003	AB	1	`a50c72e98297…`

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 10 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Omeprazole	OMEPRAZOLE	Chartwell RX, LLC	10f5502a-2e63-4f2a-a3ba-ddc5bd403051	2025-12-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075410 application number: ANDA075410
Omeprazole	OMEPRAZOLE	PD-Rx Pharmaceuticals, Inc.	ed9895ae-3d18-434c-8b56-47bccdc8fe6d	2025-10-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075410 application number: ANDA075410
Omeprazole	OMEPRAZOLE	NuCare Pharmaceuticals,Inc.	ad675ef6-5377-b9f2-e053-2995a90a06e9	2024-07-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075410 application number: ANDA075410
Omeprazole	OMEPRAZOLE	NuCare Pharmaceuticals,Inc.	55a1fb3c-f040-2e39-e054-00144ff8d46c	2024-07-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075410 application number: ANDA075410
Omeprazole	OMEPRAZOLE	NuCare Pharmaceuticals,Inc.	8991d464-7abc-4350-e053-2995a90a4ea7	2024-06-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075410 application number: ANDA075410
Omeprazole	OMEPRAZOLE	Bryant Ranch Prepack	1318a1c1-222d-471a-92d6-3632c82fb999	2024-05-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075410 application number: ANDA075410
Omeprazole	OMEPRAZOLE	Bryant Ranch Prepack	18f5a7cc-40d8-4aeb-a601-47bc9024f130	2024-05-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075410 application number: ANDA075410
Omeprazole	OMEPRAZOLE	Lannett Company, Inc.	92201fb1-4570-42db-8da3-3b8c0e291d32	2023-04-21	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075410 application number: ANDA075410
Omeprazole	OMEPRAZOLE	Proficient Rx LP	9786b04f-f827-460b-91bc-c0ac967f95dd	2022-11-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075410 application number: ANDA075410
Omeprazole	OMEPRAZOLE	Aphena Pharma Solutions - Tennessee, LLC	4b188d97-f1b3-468d-9818-b8333bf24b5a	2020-12-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075410 application number: ANDA075410

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
50268-619-15	2022-01-31	C162847	48780-1	d6a99b39-834f-a426-e053-dadaa90af4c2	Omeprazole Delayed-Release Capsules, USP Rx Only These highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. OMEPRAZOLE Delayed-Release Capsules USP Initial U.S. Approval: 1989
50268-619-15	2022-01-28	C162847	48780-1	d6a99b39-834f-a426-e053-dadaa90af4c2	Omeprazole Delayed-Release Capsules, USP Rx Only These highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. OMEPRAZOLE Delayed-Release Capsules USP Initial U.S. Approval: 1989

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50268-619-11	EA - Each	50268-619	97c18daf-0c85-4557-af27-9eee973ce946	1	2015-05-05
50268-619-15	EA - Each	50268-619	f0b376fc-7c54-4d0a-a5af-f1456d5b9abb	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
OMEPRAZOLE	ACTIVE INGREDIENT	KG60484QX9	OMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]	19
OMEPRAZOLE	ACTIVE MOIETY	KG60484QX9	OMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]	19
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	OMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]	19
ALUMINUM CHLOROHYDREX PROPYLENE GLYCOL	INACTIVE INGREDIENT	PGG6VG42HP	OMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]	19
AMMONIA	INACTIVE INGREDIENT	5138Q19F1X	OMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]	19
BUTYL ALCOHOL	INACTIVE INGREDIENT	8PJ61P6TS3	OMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]	19
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	OMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]	19
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	OMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]	19
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	OMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]	19
GELATIN	INACTIVE INGREDIENT	2G86QN327L	OMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]	19
Glyceryl Dibehenate	INACTIVE INGREDIENT	R8WTH25YS2	OMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]	19
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	OMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]	19
ISOPROPYL ALCOHOL	INACTIVE INGREDIENT	ND2M416302	OMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]	19
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	OMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]	19
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)	INACTIVE INGREDIENT	74G4R6TH13	OMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]	19
SHELLAC	INACTIVE INGREDIENT	46N107B71O	OMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]	19
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	OMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]	19
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	OMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]	19
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	OMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]	19
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	OMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]	19
TRIETHYL CITRATE	INACTIVE INGREDIENT	8Z96QXD6UM	OMEPRAZOLE (OMEPRAZOLE) CAPSULE, DELAYED RELEASE [AVPAK]	19

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
KG60484QX9	OMEPRAZOLE	73590-58-6	OMEPRAZOLE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
50268-619-15	50268061915	50 BLISTER PACK in 1 BOX (50268-619-15) > 1 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (50268-619-11)	50 blister pack	2011-07-12	0000-00-00	No	No	Current